AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue
+6.03%
EPS
−73.9%
Free cash flow
−16.9%
Total debt
+14.6%

Quarter to September 2026, against a year earlier

143.84 3.02 −2.06%
Market cap
$9.1B
P/E
34.6×
Fwd P/E
25.9×
Dividend yield
1.00%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100

AptarGroup, Inc. (ATR) Operating cash flow

Alert me on Operating cash flow

AptarGroup, Inc.'s operating cash flow for fiscal 2025 was $570.0M, down 11.4% from $643.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was $573.5M. Over the past ten years it has ranged from $313.6M (fiscal 2018) to $643.4M (fiscal 2024); the current reading is higher than 73% of that period. AptarGroup, Inc. ranks 11th of 51 Medical Instruments & Supplies companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $570.0M (11.41%)
FY2024 $643.4M 11.85%
FY2023 $575.2M 20.19%
FY2022 $478.6M 31.69%
FY2021 $363.4M (36.26%)
FY2020 $570.2M 10.83%
FY2019 $514.5M 64.03%
FY2018 $313.6M (3.42%)
FY2017 $324.7M (0.18%)
FY2016 $325.3M 0.48%

Quarterly newest first

Period Operating cash flow Change
Sep 2026 $167.6M 61.95%
Jun 2026 $103.5M (12.81%)
Mar 2026 $118.7M (35.38%)
Dec 2025 $183.7M 3.43%
43 more quarters

Against its own ten years

Low $313.6M High $643.4M
Ten-year median $478.6M
Current reading's percentile 73

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on ATR